Clarus Therapeutics Holdings, Inc., a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, announced it will release its third quarter 2021 financial and operating results on Thursday, November 18, 2021, after the market closes.
November 17, 2021
· 1 min read